DA32 Life Science Tech Acquisition Corp. – NASDAQ:DALS

DA32 Life Science Tech Acquisition Corp. stock price monthly change

+1.08%
month

DA32 Life Science Tech Acquisition Corp. stock price quarterly change

+1.88%
quarter

DA32 Life Science Tech Acquisition Corp. stock price yearly change

+6.62%
year

DA32 Life Science Tech Acquisition Corp. key metrics

Market Cap
 264.19M
Enterprise value
 N/A
P/E
 508.34
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 -44.33
PEG ratio
 2.20
EPS
 N/A
Revenue
 N/A
EBITDA
 -620.66K
Income
 -571.29K
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

DA32 Life Science Tech Acquisition Corp. stock price history

DA32 Life Science Tech Acquisition Corp. stock forecast

DA32 Life Science Tech Acquisition Corp. financial statements

Profit Margin

DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS): Profit margin
Dec 2021 0 -257.15K
DALS income statement history

Debt to Assets

DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS): Debt to assets
Apr 2021 95000 71.51K 75.28%
Sep 2021 202819055 5.72M 2.82%
Sep 2021 202680392 5.81M 2.87%
Dec 2021 2468243 5.88M 238.49%
DALS balance sheet history

DA32 Life Science Tech Acquisition Corp. other data

DA32 Life Science Tech Acquisition Corp.
Insider Trading

DA32 Life Science Tech Acquisition Corp. (NASDAQ:DALS): Insider trades (number of shares)
Period Buy Sel
Jul 2021 6250000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DA32 SPONSOR LLC
Class A Common Stock 650,000 $10 $6,500,000
Purchase
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Class A Common Stock 1,600,000 $10 $16,000,000
Purchase
ARCH VENTURE FUND XI, L.P.
Class A Common Stock 1,600,000 $10 $16,000,000
Purchase
CRANDELL KEITH
Class A Common Stock 1,600,000 $10 $16,000,000
Purchase
SECTION 32 FUND 3, LP
Class A Common Stock 800,000 $10 $8,000,000
DALS insider trading transactions

Frequently Asked Questions (FAQ)

  • When is DA32 Life Science Tech Acquisition Corp.'s next earnings date?

    Unfortunately, DA32 Life Science Tech Acquisition Corp.'s (DALS) next earnings date is currently unknown.

  • Does DA32 Life Science Tech Acquisition Corp. pay dividends?

    No, DA32 Life Science Tech Acquisition Corp. does not pay dividends.

  • How much money does DA32 Life Science Tech Acquisition Corp. make?

    DA32 Life Science Tech Acquisition Corp. has a market capitalization of 264.19M.

  • What is DA32 Life Science Tech Acquisition Corp.'s stock symbol?

    DA32 Life Science Tech Acquisition Corp. is traded on the NASDAQ under the ticker symbol "DALS".

  • What is DA32 Life Science Tech Acquisition Corp.'s primary industry?

    Company operates in the Financial Services sector and Shell Companies industry.

  • How do i buy shares of DA32 Life Science Tech Acquisition Corp.?

    Shares of DA32 Life Science Tech Acquisition Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When DA32 Life Science Tech Acquisition Corp. went public?

    DA32 Life Science Tech Acquisition Corp. is publicly traded company for more then 4 years since IPO on 28 Jul 2021.

  • Where are DA32 Life Science Tech Acquisition Corp.'s headquarters?

    DA32 Life Science Tech Acquisition Corp. is headquartered at 345 Park Avenue South, New York, NY.

  • How can i contact DA32 Life Science Tech Acquisition Corp.?

    DA32 Life Science Tech Acquisition Corp.'s mailing address is 345 Park Avenue South, New York, NY and company can be reached via phone at +212 5511600.

DA32 Life Science Tech Acquisition Corp. company profile:

DA32 Life Science Tech Acquisition Corp.

Exchange:

NASDAQ

Full time employees:

0

Industry:

Shell Companies

Sector:

Financial Services

DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science infrastructure sectors. DA32 Life Science Tech Acquisition Corp. was incorporated in 2021 and is based in New York, New York.

+212 5511600
345 Park Avenue South
New York, NY 10010

CIK: 0001863294
ISIN: US23312M1062
CUSIP: 23312M106